Le Lézard
Classified in: Health, Science and technology, Business
Subject: EARNINGS

BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2021


BIOQUAL, Inc. (OTC-Pink:BIOQ) (www.bioqual.com):

Nine Months Ended

 

Three Months Ended

 

 

February 28,

 

February 29,

 

February 28,

 

February 29,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Revenue

 

$

41,070,486

 

$

32,884,055

 

$

12,584,303

 

$

11,593,217

 

Income Before Income Tax

 

$

5,942,062

 

$

4,150,830

 

$

1,379,460

 

$

1,018,306

 

Net Income

 

$

4,203,962

 

$

2,936,730

 

$

975,960

 

$

720,406

 

Basic Earnings per Share

 

 

 

 

 

 

 

 

 

 

 

 

of Common Stock

$

4.70

$

3.29

$

1.09

$

.81

 

Diluted Earnings per Share

 

 

 

 

 

 

 

 

 

 

 

 

of Common Stock

$

4.70

$

3.29

$

1.09

$

.81

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

 

 

Number of Shares Outstanding

 

 

 

 

 

 

 

 

For Basic Earnings Per Share

 

893,932

 

893,416

 

894,416

 

893,416

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

 

 

Number of Shares Outstanding

 

 

 

 

 

 

 

 

For Diluted Earnings Per Share

 

893,932

 

893,843

 

894,416

 

893,843

       

For more detail related to the fiscal year 2021 unaudited third quarter results, please visit our web site at www.bioqual.com.

Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors including risks relating to the ability to continue to extend current government contracts; the Company's ability to obtain new government or commercial contracts; continued demand for the use of animal models in scientific research; the Company's ability to perform under its contracts in accordance with the requirements of the contracts; the actual costs incurred in performing the Company's contracts and its ability to manage its costs, including its capital expenditures; dependence on third parties; future capital needs; the ability to fund its capital needs through the use of its cash on hand and line of credit; and the future availability and cost of financing/capital sources to the Company.


These press releases may also interest you

at 13:30
CKPT Investors Have Opportunity to Lead Checkpoint Therapeutics, Inc. Securities Fraud Lawsuit
Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Checkpoint Therapeutics, Inc. ("Checkpoint" or the "Company") . Class Period: March 10, 2021 ?...

at 13:30
PIZZA PIZZA ROYALTY CORP. ANNOUNCES APRIL DIVIDEND and TIMING OF FIRST QUARTER 2024 RESULTS
Pizza Pizza Royalty Corp. (the "Company") today announced its monthly cash dividend of $0.0775 per share for April 2024. The dividend will be payable to shareholders of record at the close of business April 30, 2024, and will be paid on May 15,...

at 13:22
Florida's Leading Podiatric Group Takes Giant Leap Into Texas
Houston, we don't have a foot care problem ? now that Modern Foot & Ankle has moved into the Lone Star State. The podiatric group originated in Florida and has a strong presence in Tampa, Orlando, and Palm Beach. But with its recent acquisition of a...

at 13:15
Biz Apps Partner Summit for Microsoft Ecosystem to Deliver FY 25 Insights
Dynamics Communities and Community Summit North America, in collaboration with Microsoft, are introducing the Biz Apps Partner Summit to run July 24-25, 2024, in Bellevue, Washington delivering a 24-hour immersion into FY 25 priorities, opportunities...

at 13:04
Kansas City Life Announces First Quarter 2024 Results
Kansas City Life Insurance Company recorded net income of $1.6 million or $0.16 per share in the first quarter of 2024 compared to a net loss of $3.2 million or $0.33 per share in the first quarter of 2023.  The largest factor in the improvement in...

at 13:01
Timmie Dagwood, the Unseen Catalyst Behind Jan-Michael Vincent's Acting Career, Signs with EKC PR to Narrate His Story
Timmie Dagwood, the unsung hero behind the iconic actor Jan-Michael Vincent's leap into stardom, has officially partnered with EKC PR to bring his compelling narrative to the forefront. Best known for his behind-the-scenes influence that propelled...

More news about Business...


News published on and distributed by: